Formulations of oxabicycloheptanes and oxabicycloheptenes
US11931354B2 · kind B2 · utility
1Cited by
75References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 6, 2019 |
| Grant date | Mar 19, 2024 |
| Priority date | — |
| Expiry date | Dec 6, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to a pharmaceutical composition comprising a protein phosphatase 2A (PP2A) inhibitor and monosodium glutamate.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.